Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
aducanumab
biogen
biotech
alzheimer's disease
bristol-myers squibb
celgene
clinical trials
eisai
fda
gilead sciences
immunomedics
nash
ngm biopharmaceuticals
novartis
What
bio
biogen
4
×
roundup
4
×
week
drug
ipo
news
activity
adu
aducanumab
alzheimer’s
america
amyloid
angst
approvals
approved
bagged
beats
bids
billions
biogen’s
brammer
clamped
complicated
continues
convoluted
covid
delays
democrats
depression
developing
dire
dreams
economic
effects
failure
fast
fda
felt
good
Language
unset
Current search:
roundup
×
biogen
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More